Initiative emerged after a survey carried out by the Trans People Affinity Group in partnership with the People and Culture area
Soko announced that, starting this month, it will start offering benefits especially aimed at its trans employees in the process of gender transition.
The “Hormonal Aid Benefit” is a support measure in the purchase of essential medicines for hormone therapy.
“It is essential that more agencies and companies understand their role as helpers in their employees’ personal processes. The trans community, in particular, has as one of its demands the facilitation of access to healthcare and quality hormonal treatments. I am extremely pleased for everyone who will be able to benefit from this action both today and in the future that we are building together”, said Paula Saul, Soko collaborator and Leader of the Trans People Affinity Group.
The initiative arose after an internal survey carried out by the Trans People Affinity Group in partnership with the People and Culture area, which showed that 66.67% of employees were already using therapy and 33.33% could do so in a possible future. benefit scenario.
“Establishing constant dialogues and active listening are fundamental tools for implementing initiatives like this, which came from exchanges between the People & Culture team and the agency’s Transgender People Affinity Group. I leave here an invitation for other agencies and companies to reflect and mobilize to implement this type of initiative, which makes a huge difference in people’s quality of life, mental and physical health, daily and consecutive performance, and the growth and evolution of these professionals”, added Johana Quintana, Head of People & Culture at Soko.
